ICON Public (ICLR) Projected to Post Earnings on Wednesday

ICON Public (NASDAQ:ICLR - Get Free Report) is anticipated to announce its Q1 2025 earnings results after the market closes on Wednesday, April 30th. Analysts expect the company to announce earnings of $3.17 per share and revenue of $2.03 billion for the quarter.

ICON Public (NASDAQ:ICLR - Get Free Report) last posted its quarterly earnings results on Wednesday, February 19th. The medical research company reported $3.42 earnings per share for the quarter, beating analysts' consensus estimates of $3.41 by $0.01. ICON Public had a return on equity of 11.81% and a net margin of 9.56%. The company had revenue of $2.04 billion for the quarter, compared to analysts' expectations of $2.04 billion. On average, analysts expect ICON Public to post $13 EPS for the current fiscal year and $15 EPS for the next fiscal year.

ICON Public Stock Up 0.0 %

ICON Public stock traded up $0.04 during midday trading on Monday, reaching $145.00. The company's stock had a trading volume of 1,196,218 shares, compared to its average volume of 934,624. ICON Public has a fifty-two week low of $133.28 and a fifty-two week high of $347.72. The company has a quick ratio of 1.34, a current ratio of 1.26 and a debt-to-equity ratio of 0.36. The company has a market cap of $11.71 billion, a P/E ratio of 15.22, a P/E/G ratio of 1.86 and a beta of 1.24. The business has a 50-day simple moving average of $169.25 and a 200-day simple moving average of $198.88.

Analyst Ratings Changes

Several analysts have commented on the company. Robert W. Baird reduced their price objective on ICON Public from $221.00 to $203.00 and set a "neutral" rating for the company in a research note on Tuesday, March 4th. Royal Bank of Canada restated an "outperform" rating and set a $263.00 price target on shares of ICON Public in a research note on Wednesday, January 15th. William Blair restated an "outperform" rating on shares of ICON Public in a research note on Tuesday, January 14th. Citigroup cut their price objective on ICON Public from $290.00 to $215.00 and set a "buy" rating for the company in a research report on Monday, April 7th. Finally, Truist Financial cut their price objective on ICON Public from $262.00 to $208.00 and set a "buy" rating for the company in a research report on Thursday, April 10th. Seven investment analysts have rated the stock with a hold rating, eight have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, ICON Public currently has an average rating of "Moderate Buy" and an average target price of $232.67.

About ICON Public

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies.